• Português
  • -
  • English
  • Bluesky Icon
    bluesky
  • linkedin

Eduardo

Schenberg

Neuroscience and science diplomacy
  • Podcasts
  • Papers
  • Lectures / Interviews
  • Holotropic Breathwork™
  • Contact

Category: Psilocibina

Who is blind in psychedelic research?

Who is blind in psychedelic research?
Author adminPosted on 17/08/2021Categories Ayahuasca, Ketamina, LSD, MDMA, PsilocibinaLeave a comment on Who is blind in psychedelic research?

Ethical Concerns About Psilocybin Intellectual Property

Ethical Concerns About Psilocybin Intellectual Property
Author adminPosted on 05/01/202103/01/2021Categories PsilocibinaLeave a comment on Ethical Concerns About Psilocybin Intellectual Property

Psychedelic drugs as new tools in psychiatric therapeutics

Psychedelic drugs as new tools in psychiatric therapeutics
Author adminPosted on 25/06/202025/06/2020Categories LSD, MDMA, PsilocibinaLeave a comment on Psychedelic drugs as new tools in psychiatric therapeutics

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
Author adminPosted on 05/07/201818/11/2019Categories Ibogaína, Ketamina, LSD, MDMA, PsilocibinaLeave a comment on Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development

Translation and cultural adaptation of the States of Consciousness Questionnaire (SOCQ) and statistical validation of the Mystical Experience Questionnaire (MEQ30) in Brazilian Portuguese

Translation and cultural adaptation of the States of Consciousness Questionnaire (SOCQ) and statistical validation of the Mystical Experience Questionnaire (MEQ30) in Brazilian Portuguese
Author adminPosted on 04/12/201718/11/2019Categories Ayahuasca, LSD, MDMA, PsilocibinaLeave a comment on Translation and cultural adaptation of the States of Consciousness Questionnaire (SOCQ) and statistical validation of the Mystical Experience Questionnaire (MEQ30) in Brazilian Portuguese

Recent Posts

  • From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence‐Based Policy and Practice
  • Overcoming epistemic injustices in the biomedical study of ayahuasca: Towards ethical and sustainable regulation
  • Who is blind in psychedelic research?
  • Ethical Concerns About Psilocybin Intellectual Property
  • 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil

Recent Comments

    Archives

    • June 2025
    • March 2022
    • August 2021
    • January 2021
    • July 2020
    • June 2020
    • July 2018
    • December 2017

    Categories

    • Ayahuasca
    • Ibogaína
    • Ketamina
    • LSD
    • MDMA
    • Psilocibina

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Eduardo Schenberg @ 2017 - All rights reserved.

    Developed by Thiago Saccól.